Heart failure complicating acute myocardial infarction

Clinics in Geriatric Medicine

Volumn 16, Issue 3, 2000, Pages 535-547

  Aronow, Wilbert S ^b  

^a HEBREW HOSPITAL HOME   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; MAGNESIUM; MORPHINE; NORADRENALIN; OXYGEN; SPIRONOLACTONE;

ACUTE HEART INFARCTION; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG INDICATION; ELDERLY CARE; HEART FAILURE; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; OXYGEN THERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT PLANNING;

EID: 0033869863     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70027-6     Document Type: Article

References (89)

1. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction
2. Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients
3. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?
4. Echo in the elderly
5. Management of the older person with atrial fibrillation
6. Treatment of congestive heart failure in older persons
7. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus
8. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites
9. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors
10. Normal left ventricular ejection fraction in older persons with congestive heart failure
11. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease
12. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%
13. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
14. Respiratory muscle fatigue during cardiogenic shock
15. A randomized trial of propranolol in patients with acute myocardial infarction
16. Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction
17. Surgical treatment of complications of acute myocardial infarction
18. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction
19. Updated treatment for left ventricular failure and acute cardiogenic pulmonary edema
20. Remote right ventricular infarction mimicking pericardial constriction
21. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
22. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
23. Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction
24. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure
25. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction
26. Clinical characteristics and natural history of survivors of pulmonary congestion during acute myocardial infarction
27. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure
28. Arterial oxygen tension in acute myocardial infarction: Serial analysis of clinical state and blood gas changes
29. Role of nitrates in acute myocardial infarction
30. Medical therapy of acute myocardial infarction by the application of hemodynamic subsets
31. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
32. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
33. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction
34. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction
35. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
36. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
37. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six-weeks after acute myocardial infarction: The GISSI-3 trial
38. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction
39. Task force IV: Pharmacologic interventions. Emergency cardiac care
40. Beta blockade after myocardial infarction: The Norwegian Propranolol Study in high-risk patients
41. Usefulness of color Doppler flow imaging to distinguish ventricular septal defect from acute mitral regurgitation complicating acute myocardial infarction
42. Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial)
43. Effect on mortality of metoprolol in acute myocardial infarction
44. Mechanical ventilation and weaning
45. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction
46. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
47. Role of nitrates after acute myocardial infarction
48. Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial
49. Right ventricular infarction
50. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
51. Influence of gender on short- and long-term mortality after acute myocardial infarction
52. Mechanical complications of acute myocardial infarction
53. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention
54. Oral captopril versus placebo among 13,364 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1)
55. Reduction of infarct size by oxygen inhalation following acute coronary occlusion
56. Metoprolol in acute myocardial infarction (MIAMI): A randomised placebo-controlled international trial
57. Diagnosis of treatment of subacute free wall ventricular rupture after infarction
58. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
59. Utility of beta-blockade treatment for older postinfarction patients
60. Six-year follow-up of the Norwegian Multicentre Study on Timolol after acute myocardial infarction
61. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial
62. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function
63. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
64. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults
65. Mechanical complications
66. Therapy of acute myocardial infarction
67. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?
68. Effect of age on mortality, hospitalizations, and response to digoxin in patients with heart failure: The DIG study
69. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure
70. Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study
71. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
72. Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction
73. Drug treatment after acute myocardial infarction: Is treatment the same for the elderly as in the young patient?
74. Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation after myocardial infarction
75. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
76. Effects of the early administration of enalapril on mortality in patients with myocardial infarction
77. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials
78. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
79. The Beta-Blocker Pooling Project (BBPP): Subgroup findings from randomised trials in post-infarction patients
80. Effect of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
81. The effect of digoxin on mortality and morbidity in patients with heart failure
82. The effect of diltiazem on mortality and reinfarction after myocardial infarction
83. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
84. The effects of morphine on venous tone in patients with acute pulmonary edema
85. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy
86. Heart failure complicating acute myocardial infarction
87. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies
88. Evaluating effects of treatment subgroups of patients within a clinical trial: The case of non-Q wave myocardial infarction and beta blockers
89. The cardiovascular effects of morphine: The peripheral capacitance and resistance vessels in human subjects